United States securities and exchange commission logo October 3, 2023 Ram Mukunda Chief Executive Officer IGC Pharma, Inc. 10224 Falls Road Potomac, MD 20854 Re: IGC Pharma, Inc. Registration Statement on Form S-3 Filed September 29, 2023 File No. 333-274802 Dear Ram Mukunda: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Kenneth A. Schlesinger